A Study of Participants With Advanced Non-Small Cell Lung Cancer Treated With Nivolumab in France After at Least One Prior Chemotherapy-based Treatment by Lung Initiative on Sequence Therapy
Clinical trial NCT04500535 · COMPLETED
Trial details
- NCT number
- NCT04500535
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2020-09-28
- Primary completion
- 2025-04-18
- Enrollment
- 535
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.